Ines Semendric is a Research Officer with Health Evidence Synthesis, Recommendations and Impact (HESRI) at Adelaide University, Australia. She holds a Bachelor of Health and Medical Science, majoring in Neuroscience, and First Class Honours in Physiology, and recently completed her PhD in Medicine. Her work focuses on evidence synthesis, evidence translation, and clinical guideline methodology, including her ongoing contribution to the development of Australia’s first evidence-based National Motor Neurone Disease (MND) Care Guideline. Her research interests focus on cancer-related cognitive impairment (CRCI) and the translation of research evidence into clinical practice. She is a member of the Guidelines International Network (GIN), the GRADE Working Group, and Healthy Development Adelaide (HDA), and serves on the Evidence Synthesis and Translation Initiative (ESTI) Advisory Board. She has received the Outstanding Oral Presentation Award from the Australasian Cognitive Neuroscience Society (2024) and the Lions Medical Research Foundation Prize (2022).
Ines Semendric is a Research Officer with Health Evidence Synthesis, Recommendations and Impact (HESRI) at Adelaide University, Australia. She holds a Bachelor of Health and Medical Science, majoring in Neuroscience, and First Class Honours in Physiology, and recently completed her PhD in Medicine. Her work focuses on evidence synthesis, evidence translation, and clinical guideline methodology, including her ongoing contribution to the development of Australia’s first evidence-based National Motor Neurone Disease (MND) Care Guideline. Her research interests focus on cancer-related cognitive impairment (CRCI) and the translation of research evidence into clinical practice. She is a member of the Guidelines International Network (GIN), the GRADE Working Group, and Healthy Development Adelaide (HDA), and serves on the Evidence Synthesis and Translation Initiative (ESTI) Advisory Board. She has received the Outstanding Oral Presentation Award from the Australasian Cognitive Neuroscience Society (2024) and the Lions Medical Research Foundation Prize (2022).